A Study of IDRX-42 (GSK6042981) Versus (vs) Sunitinib in Participants With Gastrointestinal Stromal Tumors After Imatinib Therapy

Clinical trial NCT07218926 · RECRUITING

Trial details

NCT number: NCT07218926
Sponsor: GlaxoSmithKline
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Gastrointestinal Neoplasms

Start date: 2025-12-03
Primary completion: 2028-05-30
Enrollment: 450

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.